Uncategorized – VC Bridge

Echo Health Ventures Introduces New Innovation Alliance Bringing Together Three National Health Care Leaders to Collectively Invest in Transforming Health Care

The EIA further validates Echo’s unique model and will accelerate our work with leading entrepreneurs -Rob Coppedge, CEO Tweet...

Thrasio Tops $1 Billion in Total Capital Raised, Secures $500 million in Fresh Capital

BOSTON and NEW YORK, Jan. 11, 2021 /PRNewswire/ — Digital global consumer goods company Thrasio today announced its latest...

Z3Partners announced First Close of Tech & Digital Fund

MUMBAI, India, Jan. 11, 2021 /PRNewswire/ — Z3Partners Tech Fund (www.Z3Partners.com) announces its First Close of US$ 14 million...

NuProbe Closes $42M Fundraising

HOUSTON and SHANGHAI, Jan. 11, 2021 /PRNewswire/ — NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels,...

Medical Guardian Receives Growth Investment from Water Street Healthcare Partners

“Water Street’s investment strongly positions Medical Guardian to expand and enhance our senior health solutions.” Tweet this With the...

Brandzooka Appoints Mark IV Capital’s Michael Beaudoin To Board Of Directors

Beaudoin and his colleagues recognized that Brandzooka’s model of giving small and midsize agencies and in-house marketing teams access...

Leading Autonomous Mobile Robot Company Quicktron Completes C+ Funding Led by KION Group and Prosperity7 Ventures for Technology to Free Human Beings from Manual Handling

Underpinning the successful financing is impressive growth numbers from Quicktron in recent years. Operating income from 2017 to 2019...

Appian raises $775m reaching hard cap for second mining fund

LONDON, Jan. 11, 2021 /PRNewswire/ — Highlights Fund II oversubscribed reaching $775m hard cap bringing total under management to...

HSBC Joins MioTech’s Series B Financing Round

HONG KONG and SHANGHAI, Jan. 10, 2021 /PRNewswire/ — MioTech, the AI-based sustainability data and technology provider, announced today that...

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

SHANGHAI, Jan. 9, 2021 /PRNewswire/ — VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs...